Skip to main content
. 2021 Jun 3;8(3):191–204. doi: 10.1007/s40472-021-00331-4

Fig. 1.

Fig. 1

Agents currently approved or in development for inhibition of IL-6/IL-6R signaling. Adapted from [2]